<DOC>
	<DOCNO>NCT02823964</DOCNO>
	<brief_summary>Liprotamase consist 3 soluble , non-porcine digestive enzyme , lipase , protease , amylase , combine fix ratio . Liprotamase stable stomach formulate without enteric coat administration either capsule dose solution dissolve water juice .</brief_summary>
	<brief_title>EASY : Extended Access Sollpura Over Years</brief_title>
	<detailed_description>The purpose present study evaluate safety long-term use liprotamase management cystic fibrosis-related exocrine pancreatic insufficiency</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Exocrine Pancreatic Insufficiency</mesh_term>
	<criteria>Male female subject cystic fibrosisrelated exocrine pancreatic insufficiency receive liprotamase complete Study ANEPI3331 ( SOLUTION : Study Oral Liprotamase UnitMatched Therapy Of NonPorcine Origin Patients With Cystic Fibrosis ) Any medical , psychological , social condition may put subject increase risk participate study . Females nursing , pregnant , intend become pregnant , intend nurse time study .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>exocrine pancreatic insufficiency</keyword>
	<keyword>cystic fibrosis</keyword>
	<keyword>pancreatic enzyme replacement therapy</keyword>
</DOC>